Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Medtronic plcMDT · Entity 2888 | EVP & President Cardiovascular | September 16, 2026 | September 17, 2026 |
| NUVASIVE INCNUVA · Entity 110002 | EVP International | June 01, 2017 | June 01, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Medtronic plc
Report date September 16, 2026 · Filed September 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 42,186 |
Reported balance
After 2026-09-16 transaction · row 1
1 source rowRow 1 · 2026-09-16 · Sale · Disposed 1,483 · Balance 42,186 |
NUVASIVE INC
Report date June 01, 2017 · Filed June 01, 2017
This filing explicitly reported no securities owned.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 16, 2026 Filed Sep 17, 2026 20:17 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 1,483 | $93.65 | $138,882.95 |
DisclosureSEC source: 0001708062-26-000012 · wk-form4_1789676262.xml · nonDerivative · entry 1 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,186 Read SEC document |
| August 03, 2026 Filed Aug 4, 2026 23:58 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 65,556 | $0.00 Strike: $86.68 | $0.00 |
DisclosureSEC source: 0001708062-26-000010 · wk-form4_1785887900.xml · derivative · entry 4 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,556 Underlying: Ordinary Shares · 65,556 shares Expires 2036-08-03 F7 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2026 Filed Aug 4, 2026 23:58 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 23,074 | $0.00 | $0.00 |
DisclosureSEC source: 0001708062-26-000010 · wk-form4_1785887900.xml · derivative · entry 3 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,074 Underlying: Ordinary Shares · 23,074 shares Expires not disclosed F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F5 · derivative.exercise_date: Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029. F5 · derivative.expiration_date: Represents performance share units for which certain performance conditions will have been satisfied on April 27, 2029. F6 · derivative.underlying_shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 23,074 shares will be issued. If maximum performance metrics are achieved, 55,378 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. Read SEC document |
| August 03, 2026 Filed Aug 4, 2026 23:58 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 9,230 | $0.00 | $0.00 |
DisclosureSEC source: 0001708062-26-000010 · wk-form4_1785887900.xml · nonDerivative · entry 2 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,669 F3 · shares: Represents restricted stock units that vest 100% on the third anniversary of the date of grant. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 23:58 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 3,074 | $85.39 | $262,488.86 |
DisclosureSEC source: 0001708062-26-000010 · wk-form4_1785887900.xml · nonDerivative · entry 1 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,439 F1 · shares: Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I. F2 · balance_after: Includes 286 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| June 08, 2026 Filed Jun 9, 2026 20:16 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 228 | $80.45 | $18,342.60 |
DisclosureSEC source: 0001708062-26-000008 · wk-form4_1781036194.xml · nonDerivative · entry 2 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,227 Read SEC document |
| June 08, 2026 Filed Jun 9, 2026 20:16 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 3,961 | $80.44 | $318,622.84 |
DisclosureSEC source: 0001708062-26-000008 · wk-form4_1781036194.xml · nonDerivative · entry 1 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,455 Read SEC document |
| June 04, 2026 Filed Jun 8, 2026 21:07 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 6,817 | $83.32 | $567,992.44 |
DisclosureSEC source: 0001708062-26-000006 · wk-form4_1780952847.xml · nonDerivative · entry 1 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,416 F1 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on April 24, 2026. Read SEC document |
| May 26, 2026 Filed May 28, 2026 20:25 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionPerformance Share Unit · Derivative | 14,517 | $0.00 | $0.00 |
DisclosureSEC source: 0001708062-26-000004 · wk-form4_1779999902.xml · derivative · entry 2 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 14,517 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · derivative.exercise_date: The performance share units vested on April 24, 2026. F4 · derivative.expiration_date: The performance share units vested on April 24, 2026. Read SEC document |
| May 26, 2026 Filed May 28, 2026 20:25 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 15,195 | $0.00 | $0.00 |
DisclosureSEC source: 0001708062-26-000004 · wk-form4_1779999902.xml · nonDerivative · entry 1 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares issued upon the settlement of performance-vesting share units granted on July 31, 2023, based on performance as certified on May 26, 2026. F2 · balance_after: Includes 270 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| February 19, 2026 Filed Feb 26, 2026 22:48 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 385 | $0.00 Strike: $80.00 | $0.00 |
DisclosureSEC source: 0001708062-26-000002 · wk-form4_1772146125.xml · derivative · entry 11 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,155 Underlying: Ordinary Shares · 385 shares Expires 2034-07-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2026 Filed Feb 26, 2026 22:48 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 19,923 | $0.00 Strike: $87.76 | $0.00 |
DisclosureSEC source: 0001708062-26-000002 · wk-form4_1772146125.xml · derivative · entry 10 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,926 Underlying: Ordinary Shares · 19,923 shares Expires 2033-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2026 Filed Feb 26, 2026 22:48 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionStock Option (Right to Buy) · Derivative | 30,568 | $0.00 Strike: $93.08 | $0.00 |
DisclosureSEC source: 0001708062-26-000002 · wk-form4_1772146125.xml · derivative · entry 9 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,606 Underlying: Ordinary Shares · 30,568 shares Expires 2032-08-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2026 Filed Feb 26, 2026 22:48 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 385 | $97.82 | $37,660.70 |
DisclosureSEC source: 0001708062-26-000002 · wk-form4_1772146125.xml · nonDerivative · entry 8 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,768 Read SEC document |
| February 19, 2026 Filed Feb 26, 2026 22:48 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 668 | $97.83 | $65,347.10 |
DisclosureSEC source: 0001708062-26-000002 · wk-form4_1772146125.xml · nonDerivative · entry 7 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,153 Read SEC document |
| February 19, 2026 Filed Feb 26, 2026 22:48 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 19,255 | $97.77 | $1,882,561.35 |
DisclosureSEC source: 0001708062-26-000002 · wk-form4_1772146125.xml · nonDerivative · entry 6 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,821 Read SEC document |
| February 19, 2026 Filed Feb 26, 2026 22:48 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 30,568 | $97.66 | $2,985,374.81 |
DisclosureSEC source: 0001708062-26-000002 · wk-form4_1772146125.xml · nonDerivative · entry 5 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,076 F2 · price: The price reported is a weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $97.60 to $97.775. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request. Read SEC document |
| February 19, 2026 Filed Feb 26, 2026 22:48 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 1,648 | $97.86 | $161,273.28 |
DisclosureSEC source: 0001708062-26-000002 · wk-form4_1772146125.xml · nonDerivative · entry 4 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,644 Read SEC document |
| February 19, 2026 Filed Feb 26, 2026 22:48 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 385 | $80.00 | $30,800.00 |
DisclosureSEC source: 0001708062-26-000002 · wk-form4_1772146125.xml · nonDerivative · entry 3 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,292 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2026 Filed Feb 26, 2026 22:48 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 19,923 | $87.76 | $1,748,442.48 |
DisclosureSEC source: 0001708062-26-000002 · wk-form4_1772146125.xml · nonDerivative · entry 2 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2026 Filed Feb 26, 2026 22:48 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 30,568 | $93.08 | $2,845,269.44 |
DisclosureSEC source: 0001708062-26-000002 · wk-form4_1772146125.xml · nonDerivative · entry 1 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,984 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 239 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 21:11 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 1,702 | $101.36 | $172,514.72 |
DisclosureSEC source: 0001708062-25-000005 · wk-form4_1765314675.xml · nonDerivative · entry 1 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,177 F1 · shares: Represents shares withheld for taxes upon the vesting of restricted stock units previously reported on Table I. F2 · balance_after: Includes 264 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
| September 03, 2025 Filed Sep 5, 2025 20:18 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 200 | $91.59 | $18,318.00 |
DisclosureSEC source: 0001613103-25-000165 · wk-form4_1757103490.xml · nonDerivative · entry 2 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,615 Read SEC document |
| September 03, 2025 Filed Sep 5, 2025 20:18 UTC | Medtronic plc MDT · Entity 2888 | SaleOrdinary Shares | 8,405 | $91.58 | $769,729.90 |
DisclosureSEC source: 0001613103-25-000165 · wk-form4_1757103490.xml · nonDerivative · entry 1 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,815 Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:16 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionPerformance Share Unit · Derivative | 10,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000129 · wk-form4_1754338594.xml · derivative · entry 4 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 10,457 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F5 · derivative.exercise_date: The performance share units vested on August 1, 2025. F5 · derivative.expiration_date: The performance share units vested on August 1, 2025. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:16 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 2,896 | $89.34 | $258,728.64 |
DisclosureSEC source: 0001613103-25-000129 · wk-form4_1754338594.xml · nonDerivative · entry 3 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,220 F3 · shares: Represents shares withheld for payment of taxes upon the vesting of restricted stock units previously reported on Table I. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:16 UTC | Medtronic plc MDT · Entity 2888 | Tax withholdingOrdinary Shares | 4,659 | $89.34 | $416,235.06 |
DisclosureSEC source: 0001613103-25-000129 · wk-form4_1754338594.xml · nonDerivative · entry 2 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,116 F2 · shares: Represents shares withheld for taxes upon the settlement of performance-vesting restricted stock units that vested on August 1, 2025. Read SEC document |
| August 01, 2025 Filed Aug 4, 2025 20:16 UTC | Medtronic plc MDT · Entity 2888 | Exercise / conversionOrdinary Shares | 10,457 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000129 · wk-form4_1754338594.xml · nonDerivative · entry 1 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,775 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents shares issued upon the settlement of performance-vesting restricted stock units granted on August 1, 2022 and earned dividend equivalents. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:15 UTC | Medtronic plc MDT · Entity 2888 | GrantStock Option (Right to Buy) · Derivative | 53,671 | $0.00 Strike: $91.97 | $0.00 |
DisclosureSEC source: 0001613103-25-000111 · wk-form4_1753906554.xml · derivative · entry 3 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,671 Underlying: Ordinary Shares · 53,671 shares Expires 2035-07-28 F6 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:15 UTC | Medtronic plc MDT · Entity 2888 | GrantPerformance Share Units · Derivative | 19,028 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000111 · wk-form4_1753906554.xml · derivative · entry 2 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,028 Underlying: Performance Share Unit · 19,028 shares Expires not disclosed F3 · derivative.exercise_price: Each performance share unit represents a contingent right to receive one share of Medtronic common stock. F4 · derivative.exercise_date: Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028. F4 · derivative.expiration_date: Represents performance share units for which certain performance conditions will have been satisfied on April 28, 2028. F5 · derivative.underlying_shares: The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 19,028 shares will be issued. If maximum performance metrics are achieved, 38,056 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. Read SEC document |
| July 28, 2025 Filed Jul 30, 2025 20:15 UTC | Medtronic plc MDT · Entity 2888 | GrantOrdinary Shares | 7,612 | $0.00 | $0.00 |
DisclosureSEC source: 0001613103-25-000111 · wk-form4_1753906554.xml · nonDerivative · entry 1 KIIL HARRY SKIP · CIK 0001708062 · EVP & President Cardiovascular 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,318 F1 · shares: Represents restricted stock units that vest 100% on the third anniversary of the date of grant. F2 · balance_after: Includes 264 shares acquired through dividend reinvestment since the last report filed by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.